0.56
6.01%
-0.0358
IGC Pharma Inc Borsa (IGC) Ultime notizie
Is IGC Pharma Inc (AMEX: IGC) A Good Investment For New Investors Now? – Stocks Register - Stocks Register
Stocks Register
Top investors say IGC Pharma Inc (IGC) ticks everything they need – Sete News - SETE News
SETE News
6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without ... - Marketscreener.com
Marketscreener.com
6.7 Million Americans Live With Alzheimer's – IGC Pharma Believes They Deserve Treatment Options Without Black ... - Nasdaq
Nasdaq
Wall Street analysts' outlook for IGC Pharma Inc (IGC) – Sete News - SETE News
SETE News
Was there any good news for IGC Pharma Inc (IGC) stock in the last session? – US Post News - US Post News
US Post News
IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheim - Benzinga
Benzinga
IGC Pharma Adds Advisor in Artificial Intelligence - Business Wire
Business Wire
India Globalization Capital: Breakthrough in Alzheimer's Treatment Trial - TipRanks.com - TipRanks
TipRanks
IGC PHARMA INC Trade Ideas — GETTEX:IGS1 — TradingView - TradingView
TradingView
Where Will IGC Pharma Inc (IGC) Stock Go Next After It Has Risen 15.79% in a Week? - InvestorsObserver
InvestorsObserver
IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock - Business Wire
Business Wire
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024 - Yahoo Finance
Yahoo Finance
IGC Pharma Appoints Terry Lierman as an Independent Director to its Board of Directors - citybiz
citybiz
Igc Pharma reports enhanced memory function with TGR-63 an Alzheimer's mouse model - BioWorld Online
BioWorld Online
IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a "Buy" Recommendation and $3.00 Price Target - Yahoo Finance
Yahoo Finance
IGC Pharma reports higher net losses amid revenue dip in Q3 - Green Market Report
Green Market Report
IGC Pharma Reports Third Quarter Fiscal 2024 Results - Yahoo Finance
Yahoo Finance
Igc's TGR-63 helps normalize emotional and behavioral responses in Alzheimer's model - BioWorld Online
BioWorld Online
IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model - Business Wire
Business Wire
Why IGC Pharma Stock Is Moving Higher - IGC Pharma (AMEX:IGC) - Benzinga
Benzinga
IGC Pharma doses first patient with Alzheimer's therapy - Clinical Trials Arena
Clinical Trials Arena
Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer's - Yahoo Finance
Yahoo Finance
IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials - Business Wire
Business Wire
IGC Pharma Signs Master Agreement with Leading South American University - AiThority
AiThority
IGC signs agreement to adopt AI solutions into drug discovery - Pharmaceutical Technology
Pharmaceutical Technology
IGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives - Business Wire
Business Wire
IGC powers Alzheimer's and cannabis research with AI - Clinical Trials Arena
Clinical Trials Arena
IGC Pharma adds University of Puerto Rico to IGC-AD1 trial sites - Clinical Trials Arena
Clinical Trials Arena
IGC Pharma, Inc. Presenting 6 Posters on the Positive Impact of IGC-AD1 on Neuropsychiatric Symptoms in Dementia ... - Business Wire
Business Wire
IGC Pharma Secures $12 Million Line of Credit from O-Bank Strengthening Efforts in Alzheimer's Research - Yahoo Finance
Yahoo Finance
IGC Pharma Announces a $3 Million Private Placement of its Common Stock - Business Wire
Business Wire
IGC Announces Rebranding, Changes Name to IGC Pharma, Inc. - GlobeNewswire
GlobeNewswire
IGC starts clinical trial of drug candidate to treat agitation in dementia - Clinical Trials Arena
Clinical Trials Arena
India Globalization Capital, Inc. (IGC) Announces Final Approval of Settlement of Shareholder Class Action Lawsuits - Business Wire
Business Wire
All the potential red flags for investors in IGC, the pot stock that jumped 1,000% in three months - MarketWatch
MarketWatch
Dubious pot stock IGC has trading suspended, shares to be delisted - MarketWatch
MarketWatch
Capitalizzazione:
|
Volume (24 ore):